Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023)
Authors:
- Emad Uddin SajidESEmad Uddin Sajid
- Ayesha IrfanAIAyesha Irfan
- Muhammad KashanMKMuhammad Kashan
- Syed Rayyan AhmedSASyed Rayyan Ahmed
- Muhammad Hasnain AzeemMAMuhammad Hasnain Azeem
- Tooba AliTATooba Ali
- Mabel WaqarMWMabel Waqar
- Muneeba KhanMKMuneeba Khan
- Erum Shahzadi MalikEMErum Shahzadi Malik
- Md Ariful HaqueMd Ariful Haque
Open Access
- 27 July 2026
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 49 (8)
Abstract
Background: This study evaluates national trends in heart failure (HF) and psychoactive substance abuse‐related mortality among adults aged 25 years and older in the United States (US) from 1999 to 2023, stratified by sex, age, race/ethnicity, geographic regions, and the COVID‐19 pandemic period. Methods: Data from 1999 to 2023 were extracted from the CDC WONDER database. Age‐adjusted mortality rates (AAMR) and annual percentage changes (APC) were calculated using Joinpoint regression. ICD‐10 codes I50, I50.1, I50.9 (Heart Failure), and F10‐19 (Psychoactive Substance Use) were used to identify the conditions. Results: A total of 771 739 deaths were recorded from 1999 to 2023 among individuals aged 25 and older. Most deaths occurred in medical facilities (39.24%), followed by decedents' homes (34.14%), long‐term care facilities (16.30%), hospice (6.65%), and other settings (3.67%). The AAMR increased markedly from 1.68 in 1999 to 20.7 in 2023 (AAPC of 12.09, 95% confidence interval [CI]: 10.97−14.26). A substantial increase was observed from 1999 to 2005 (APC: 38.5%, 95% CI: 29.1–55.8), followed by a slower increase until 2020 (APC: 5.68%, 95% CI: 5.02–14.8). Men showed consistently higher AAMRs than females (18.8 vs. 8.65). By age group, mortality was highest among individuals aged 65 years and older. Conclusion: Using CDC WONDER data (1999–2023), we found a sharp rise in HF mortality linked to psychoactive substance abuse, from 1.68 to 20.7 per 100 000. Mortality burden was highest among males, older adults, non‐Hispanic White individuals, and rural populations, highlighting widening demographic and geographic disparities.Keywords
This publication has 30 references indexed in Scilit:
- The Overlooked Crisis: Drug Self-Intoxication Mortality Increased at 5 Times the Rate of Suicide Mortality During the US Opioid Epidemic (1999-2023)Mayo Clinic Proceedings, 2026
- Drugs of Abuse and Heart FailureJournal of Cardiac Failure, 2021
- Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups – United States, 2004–2019Drug and Alcohol Dependence, 2021
- Cardiovascular Complications of Opioid UseJACC, 2021
- Patterns of polysubstance use and simultaneous co-use in high risk young adultsDrug and Alcohol Dependence, 2019
- Comprehensive review of cardiovascular toxicity of drugs and related agentsMedicinal Research Reviews, 2018
- The prescription opioid epidemic: an overview for anesthesiologistsCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2015
- Alcoholic Cardiomyopathy: A ReviewJournal of Cardiac Failure, 2011
- Coronary heart disease outcomes among chronic opioid and cyclooxygenase‐2 users compared with a general population cohortPharmacoepidemiology and Drug Safety, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008